recent
year
signific
increas
detect
enteroviru
among
patient
sever
respiratori
infect
worldwid
recogn
reemerg
pathogen
howev
due
lack
permiss
anim
model
comprehens
understand
pathogenesi
immun
respons
hamper
recent
shown
strong
affin
sialic
acid
sa
shown
previous
sa
abundantli
present
respiratori
tract
cotton
rat
sigmodon
hispidu
thu
hypothes
cotton
rat
could
potenti
model
infect
evalu
abil
two
recent
isol
strain
mo
along
histor
prototyp
fermon
strain
atcc
infect
cotton
rat
found
cotton
rat
permiss
infect
without
viru
adapt
differ
strain
show
variabl
infect
profil
abil
produc
neutral
antibodi
na
upon
intranas
infect
intramuscular
immun
infect
result
signific
induct
pulmonari
cytokin
gene
express
lung
patholog
intramuscular
immun
live
induc
strong
homolog
antibodi
respons
moder
heterolog
na
respons
show
passiv
prophylact
administr
serum
high
content
na
result
effici
antivir
therapi
anim
show
complet
protect
challeng
induc
strong
pulmonari
cytokin
respons
enhanc
lung
patholog
indic
gener
exacerb
immun
respons
immun
conclus
data
illustr
cotton
rat
power
anim
model
provid
experiment
platform
investig
pathogenesi
immun
respons
antivir
therapi
vaccin
infect
picornavirus
genu
enteroviru
ev
compris
mani
human
pathogen
caus
common
infect
human
ev
ad
rhinoviru
rv
ac
ev
small
singlestrand
positivesens
rna
virus
genom
kb
encapsid
icosahedr
capsid
form
nonenvelop
virion
around
nm
diamet
total
type
evd
speci
associ
acut
hemorrhag
conjunct
caus
agent
acut
flaccid
paralysi
identifi
nonhuman
primat
first
isol
four
hospit
pediatr
patient
pneumonia
bronchiol
california
indic
initi
tropism
target
respiratori
tract
three
major
clade
design
b
c
circul
worldwid
genom
consist
singl
open
read
frame
orf
encod
four
structur
protein
seven
nonstructur
protein
flank
long
untransl
region
utr
hairpinloop
secondari
structur
short
poli
tract
sinc
discoveri
infect
among
rare
report
earli
howev
upsurg
detect
document
last
decad
among
patient
acut
respiratori
infect
variou
sever
rang
mild
upper
respiratori
tract
infect
sever
pneumonia
includ
fatal
pediatr
adult
patient
largest
outbreak
infect
usa
report
midaugust
januari
total
case
respiratori
ill
caus
state
district
columbia
report
confirm
either
center
diseas
control
prevent
cdc
differ
state
public
health
laboratori
case
children
larg
percentag
requir
pediatr
intens
care
case
fatal
previous
detect
cerebrospin
fluid
csf
yearold
boy
die
due
meningomyeloenceph
pneumonia
usa
outbreak
geograph
tempor
defin
cluster
case
acut
flaccid
paralysi
cranial
nerv
dysfunct
also
report
children
viru
detect
sporad
nasopharyng
sampl
addit
case
pediatr
infect
associ
acut
flaccid
paralysi
also
report
europ
total
case
acut
flaccid
myeliti
confirm
state
case
report
august
limit
sporad
case
detect
across
usa
report
rais
concern
genet
chang
could
contribut
increas
detect
viru
human
respiratori
infect
increas
diseas
sever
neurolog
symptom
thu
recogn
reemerg
pathogen
current
specif
antivir
therapi
avail
treatment
primarili
support
furthermor
suitabl
anim
model
avail
develop
test
therapeut
viru
obtain
comprehens
understand
pathogenesi
year
genom
undergon
mani
delet
spacer
region
utr
end
intern
ribosom
entri
site
ire
polyprotein
orf
signific
delet
clear
howev
mutat
might
influenc
translat
effici
therebi
affect
viral
virul
clade
b
divid
subclad
basi
amino
acid
substitut
structur
nonstructur
protein
compar
clade
b
clade
c
geograph
restrict
circul
japan
itali
subclad
consid
endem
found
mani
countri
outbreak
thailand
unit
kingdom
china
philippin
netherland
outbreak
subclad
domin
among
usa
case
specimen
collect
kansa
citi
mo
anoth
report
show
major
strain
circul
outbreak
specimen
collect
lower
hudson
valley
new
york
differ
significantli
prior
one
mostli
three
nucleotid
variabl
belong
new
clade
sialic
acid
sa
receptor
use
glycan
array
enzymat
modifi
erythrocyt
shown
stronger
affin
sa
sa
sa
receptor
induc
cascad
conform
chang
viru
prime
viral
uncoat
facilit
cell
entri
lectinbas
stain
show
sa
receptor
present
respiratori
tract
cotton
rat
sa
receptor
found
ciliat
cell
wherea
sa
receptor
associ
mucinproduc
cell
cotton
rat
trachea
cotton
rat
lung
parenchyma
show
consist
stain
type
type
ii
pneumocyt
sa
undetect
level
sa
consist
observ
shown
influenza
human
avian
origin
well
influenza
b
isol
replic
without
need
adapt
cotton
rat
upper
lower
respiratori
tract
addit
report
intranas
infect
cotton
rat
anoth
picornaviru
human
rhinoviru
hrv
type
result
isol
infect
viru
lower
respiratori
tract
patholog
mucu
product
express
interferonactiv
gene
without
genet
modif
either
host
viru
contrast
ev
biolog
similar
hrv
fact
discov
subsequ
reclassifi
base
molecular
analysi
similar
rv
grow
optim
compar
prefer
ev
heat
acid
labil
present
studi
evalu
three
strain
belong
differ
clade
abil
infect
cotton
rat
report
intranas
infect
cotton
rat
result
isol
infect
viru
nose
lung
tissu
express
lung
inflammatori
cytokin
mark
lung
patholog
infect
immun
cotton
rat
live
gener
variou
level
protect
viru
challeng
correl
product
differ
level
serum
na
furthermor
demonstr
model
could
excel
tool
deciph
crossreact
immun
among
differ
clade
relev
gener
efficaci
vaccin
broad
protect
conclud
infect
cotton
rat
provid
novel
insight
enabl
molecular
dissect
immun
respons
thu
develop
effect
intervent
prevent
strategi
work
three
differ
strain
use
encompass
clade
b
repres
histor
appear
relev
usa
classifi
three
strain
classic
atcc
access
refer
atcc
prototyp
fermon
viru
strain
purchas
atcc
fermon
strain
oldest
sequenc
genbank
collect
california
sequenc
atcc
strain
cluster
near
root
phylogenet
tree
reflect
sampl
date
fig
preoutbreak
isol
access
refer
vanbt
collect
nashvil
tn
vanderbilt
univers
medic
center
belong
subclad
fig
outbreak
isol
access
refer
mo
collect
kansa
citi
mo
outbreak
belong
subclad
fig
three
strain
propag
hela
cell
titer
determin
standard
endpoint
dilut
assay
express
tcid
ml
infect
group
adult
cotton
rat
tcid
strain
five
anim
per
group
euthan
h
post
infect
pi
determin
viral
titer
nose
lung
anim
fig
atcc
viru
recov
lung
nose
h
pi
wherea
detect
strain
almost
neglig
tissu
h
pi
one
anim
exhibit
viru
nose
vanbt
consist
recov
nose
lung
tissu
h
pi
amount
vanbt
viru
recov
gener
higher
lung
nose
h
pi
fig
decreas
recov
infecti
vanbt
titer
around
log
tissu
h
pi
compar
h
titer
nose
lung
tissu
compar
among
anim
h
pi
log
tcid
g
tissu
isol
less
consist
h
pi
fig
overal
result
show
vanbt
replic
strongli
atcc
cotton
rat
thu
use
vanbt
subsequ
infect
experi
adult
cotton
rat
infect
tcid
vanbt
inocul
ident
amount
uvinactiv
vanbt
viru
uvvanbt
group
anim
euthan
h
pi
measur
profil
viru
replic
nose
lung
tissu
fig
respect
vanbt
viru
detect
nose
h
show
brief
defin
drop
h
pi
p
h
compar
h
p
titer
correspond
viral
eclips
subsequ
increas
h
reach
peak
tissu
h
pi
p
h
compar
h
pi
titer
fig
infecti
viru
almost
undetect
h
pi
nose
lung
viru
titer
remain
constant
h
pi
subsequ
decreas
undetect
level
h
fig
expect
infecti
viru
detect
lung
nose
anim
inocul
uvvanbt
fig
determin
whether
sexbia
replic
cotton
rat
compar
viru
yield
h
pi
nose
lung
tissu
male
femal
cotton
rat
vanbt
titer
recov
tissu
essenti
ident
anim
differ
sex
fig
vanbt
extent
viral
replic
also
assess
determin
amount
neg
strand
viral
rna
vrna
replic
intermedi
qrtpcr
vrna
strand
detect
lung
infect
anim
h
pi
fig
insert
level
vrna
lung
briefli
peak
h
maintain
brief
plateau
h
follow
decreas
final
clearanc
viral
intermedi
h
pi
similar
vrna
quantif
total
vanbt
vrna
qrtpcr
show
almost
compar
pattern
fig
anim
inocul
uvvanbt
show
undetect
level
vrna
total
vrna
fig
fig
set
anim
infect
differ
strain
atcc
vanbt
mo
follow
day
challeng
determin
whether
infect
three
strain
induc
immunolog
respons
form
na
titer
parallel
variou
level
replic
cotton
rat
vanbt
infect
gener
highest
na
titer
infect
anim
show
detect
homolog
na
titer
infect
show
one
anim
detect
na
titer
atcc
infect
result
detect
na
respons
fig
moreov
na
titer
vanbt
persist
compar
strength
week
pi
fig
determin
effect
infect
induct
inflammatori
respons
focus
lung
tissu
measur
express
cotton
rat
mrna
sever
chemokin
type
type
ii
interferon
ifn
cytokin
select
ifninduc
gene
follow
vanbt
infect
cotton
rat
infect
vanbt
uvvanbt
euthan
indic
time
point
measur
level
gene
express
qrtpcr
fig
vanbt
infect
dramat
induc
earli
product
neutrophil
chemoattract
chemokin
gro
monocyt
chemotact
protein
peak
within
h
sharpli
decreas
basal
level
h
infect
differ
profil
found
chemokin
rant
induc
delay
kinet
peak
within
h
pi
express
ifnmrna
gradual
peak
h
remain
high
h
pi
wherea
express
ifninduc
gene
consist
induc
follow
peak
peak
h
remain
detect
h
pi
fig
addit
vanbt
infect
induc
proinflammatori
cytokin
differ
peak
time
peak
h
show
late
express
remain
higher
h
pi
fig
addit
measur
express
cytokin
eg
none
show
signific
express
lung
tissu
upon
vanbt
infect
see
consist
result
pulmonari
inflammatori
gene
express
lung
patholog
moder
peak
h
pi
character
presenc
mild
signific
increas
cumul
patholog
includ
bronchiol
perivascul
interstiti
pneumonia
alveol
fig
examin
h
estain
lung
section
reveal
area
extens
peribronchi
alveolar
cellular
infiltr
vanbtinfect
anim
evidenc
lung
control
uvvanbt
inocul
anim
fig
na
pivot
prevent
viral
infect
block
viral
replic
next
investig
effect
im
immun
live
strain
gener
humor
protect
immun
respons
measur
serum
na
differ
strain
immun
group
adult
cotton
rat
im
three
strain
either
live
uvinactiv
dose
tcid
day
boost
week
first
immun
dose
viru
serum
sampl
collect
anim
boost
week
first
immun
homolog
heterolog
na
level
determin
vitro
neutral
assay
sign
clinic
diseas
seen
anim
immun
im
either
inactiv
live
virus
immun
live
atcc
vanbt
induc
homolog
na
titer
sera
week
postimmun
increas
week
due
boost
fig
week
serum
sampl
anim
immun
live
atcc
show
lowest
na
titer
log
follow
group
immun
log
wherea
anim
immun
live
vanbt
show
highest
titer
log
fig
tabl
intens
induct
homolog
na
titer
follow
im
immun
live
viru
mirror
respect
infect
cotton
rat
fig
similar
anim
im
immun
uvvanbt
induc
detect
na
titer
fig
tabl
next
test
whether
vanbt
replic
site
im
inocul
thu
enhanc
na
product
group
cotton
rat
mockinocul
im
pb
inocul
im
live
vanbt
sacrif
h
post
inocul
vanbt
vrna
measur
rna
sampl
extract
inguin
lumbar
lymph
node
drain
site
inocul
week
boost
week
first
immun
homolog
serum
na
titer
determin
sera
assay
duplic
na
titer
express
log
geometr
mean
se
n
two
independ
experi
p
week
na
titer
compar
week
na
b
passiv
transfer
vanbt
immun
sera
protect
anim
vanbt
challeng
anim
treat
intraperiton
ml
x
pb
mock
serum
anim
immun
im
either
uvvanbt
vanbt
follow
day
anim
challeng
tcid
vanbt
euthan
h
later
determin
nose
lung
viral
titer
n
per
group
p
group
compar
mock
group
vrna
strand
detect
lymph
node
vanbt
inocul
anim
fig
level
vrna
h
almost
compar
decreas
h
post
inocul
next
sought
determin
capac
serum
sampl
neutral
virus
differ
clade
use
immun
test
crossreact
immun
serum
one
viru
strain
use
measur
abil
neutral
two
viru
strain
vitro
shown
tabl
atcc
immun
sera
gener
measur
homolog
na
titer
neglig
na
titer
vanbt
vanbt
immun
sera
show
strong
homolog
na
respons
also
moder
heterolog
respons
two
strain
howev
vanbt
appear
strongest
induc
na
respons
three
strain
tabl
serum
sampl
mock
pb
anim
immun
uvvanbt
show
neutral
activ
strain
data
strongli
suggest
immun
vanbt
substanti
induc
broader
na
respons
could
protect
heterolog
challeng
vanbt
gener
strong
moder
na
respons
respect
three
virus
next
test
efficaci
prophylact
administr
serum
immun
vanbt
uvvanbt
immun
mock
treat
anim
protect
vanbt
challeng
anim
receiv
immun
sera
high
na
antibodi
vanbt
intraperiton
prior
challeng
averag
na
titer
vanbt
immun
sera
log
show
signific
reduct
nose
lung
viral
titer
log
h
pi
wherea
anim
mocktreat
receiv
uvvanbt
sera
prophylact
show
signific
protect
fig
data
demonstr
passiv
transfer
antibodi
consid
effect
prophylact
therapi
infect
test
whether
na
respons
induc
immun
suffici
confer
protect
viru
challeng
group
cotton
rat
mock
immun
im
infect
vanbt
immun
im
uvvanbt
live
atcc
live
vanbt
live
fig
anim
immun
day
boost
week
wherea
vanbtinfect
group
inocul
day
week
anim
challeng
n
vanbt
sacrif
h
pi
measur
nose
lung
viral
load
shown
fig
im
immun
live
vanbt
result
complet
rapid
viru
clearanc
nose
lung
tissu
protect
detect
mockimmun
anim
anim
previous
infect
vanbt
anim
immun
uvvanbt
anim
immun
live
atcc
fig
howev
anim
show
moder
reduct
viral
titer
nose
lung
tissu
log
log
respect
fig
correl
gener
crossprotect
na
titer
model
tabl
next
examin
effect
vanbt
im
immun
type
kinet
pulmonari
cytokin
ifn
respons
vanbt
challeng
analyz
anim
mockimmun
im
primari
infect
previous
infect
vanbt
secondari
infect
immun
im
either
uvvanbt
live
vanbt
shown
primari
infect
vanbt
induc
strong
mrna
express
peak
h
pi
lung
fig
measur
express
h
pi
immun
group
fig
immun
live
vanbt
significantli
reduc
express
h
pi
compar
mockimmun
group
consist
complet
protect
seen
group
fig
addit
anim
previous
infect
vanbt
n
immun
uvvanbt
im
show
decreas
express
fig
moreov
immun
live
vanbt
show
dramat
increas
express
chemoattract
h
pi
remain
elev
even
h
pi
fig
immun
live
vanbt
elicit
strong
cytokin
respons
lung
tissu
h
remain
even
higher
h
pi
fig
anim
previous
infect
vanbt
immun
im
uvvanbt
show
higher
express
compar
mockimmun
group
although
magnitud
induct
live
vanbtimmun
group
higher
two
group
p
vanbti
compar
vanbtin
vanbtim
compar
uvvanbti
h
pi
furthermor
uvvanbt
vanbtimmun
group
show
signific
induct
signatur
cytokin
mrna
express
h
pi
fig
determin
extent
lung
patholog
four
group
score
h
estain
lung
section
shown
fig
immun
uvvanbt
live
vanbt
im
show
significantli
increas
score
vascul
interstiti
pneumonia
alveol
compar
mockimmun
previous
infect
vanbt
group
suggest
exacerb
inflammatori
respons
group
past
decad
detect
frequenc
respiratori
infect
rise
worldwid
usa
outbreak
largest
widespread
epidem
investig
date
increas
number
case
show
acut
flaccid
paralysi
cranial
nerv
dysfunct
children
rais
concern
potenti
impact
public
health
howev
underli
caus
upsurg
strain
circul
recent
year
divid
three
distinct
clade
b
c
base
phylogenet
tree
sinc
first
isol
viru
mutat
accumul
bc
de
loop
sequenc
correspond
region
protein
viral
surfac
associ
antigen
epitop
indic
uniqu
sequenc
variat
loop
may
caus
shift
antigen
current
studi
use
three
differ
strain
classic
atcc
prototyp
fermon
strain
use
refer
strain
abund
circul
viru
preoutbreak
isol
vanbt
collect
belong
subclad
consid
endem
isol
mani
differ
geograph
region
rat
model
led
conclus
replic
immunolog
profil
differ
significantli
report
bind
sa
howev
lack
suitabl
anim
model
sever
limit
studi
infect
immun
pathogenesi
test
method
intervent
prevent
strategi
speci
cotton
rat
genu
sigmodon
shown
prefer
model
impress
list
human
pathogen
includ
respiratori
syncyti
viru
rsv
influenza
b
serotyp
adenovirus
sever
serotyp
parainfluenza
viru
type
measl
herp
simplex
type
human
metapneumoviru
mani
virus
cotton
rat
repres
reliabl
model
better
mimic
human
diseas
fact
picornavirus
first
group
virus
studi
cotton
rat
initi
studi
polioviru
demonstr
lans
strain
poliomyel
select
replic
mice
process
adapt
involv
serial
passag
virus
cotton
rat
moreov
shown
strain
isol
sampl
brain
fece
children
outbreak
bulgaria
induc
paralyt
diseas
newborn
adult
cotton
rat
recent
show
cotton
rat
permiss
infect
hrv
infect
result
recoveri
infecti
viral
load
lung
day
pi
accompani
signific
patholog
mucu
product
express
inflammatori
mediat
current
anim
model
inform
regard
relev
diseaserel
outcom
human
case
limit
herein
character
infect
cotton
rat
measur
viral
load
vrna
neg
total
either
nose
lung
tissu
day
pi
assess
mrna
express
variou
chemokin
ifn
proinflammatori
cytokin
lung
histolog
focus
analysi
nose
lung
tissu
sinc
recent
case
show
respiratori
tract
evid
target
infect
viru
data
clearli
show
cotton
rat
permiss
replic
respiratori
airway
although
differ
infect
profil
among
three
strain
atcc
weakest
vanbt
show
strongest
infect
replic
profil
fig
differ
viral
replic
could
repres
differ
evolutionari
stage
three
strain
affect
variou
level
replic
virus
may
differenti
use
altern
nonsialyl
receptor
infect
cell
although
replic
cycl
vanbt
appear
shortliv
profil
viral
titer
nose
time
show
clear
viru
eclips
h
rise
quickli
reach
peak
h
pi
differ
output
viru
obtain
infect
differ
strain
demonstr
vanbt
replic
upper
respiratori
tract
cotton
rat
replic
vanbt
studi
measur
viral
replic
intermedi
vrna
show
earli
product
show
peak
h
pi
replic
rna
lung
viral
genom
replic
intermedi
vrna
show
peak
express
prior
detect
peak
infecti
viru
titer
confirm
detect
earli
product
viral
replic
eventu
increas
viral
titer
h
pi
sinc
could
detect
vanbt
primarili
nose
lung
tissu
infecti
viru
decreas
h
pi
possibl
vanbt
could
infect
limit
amount
type
cell
respiratori
tract
cotton
rat
reduc
transmiss
tissu
usa
outbreak
acut
flaccid
paralysi
occur
time
far
larger
outbreak
across
usa
vast
major
confirm
case
mostli
show
develop
respiratori
ill
viral
presenc
confirm
hand
paralyz
children
emphas
tropism
primarili
direct
upper
lower
respiratori
tract
although
rule
potenti
chang
tropism
model
event
could
human
rare
need
investig
data
show
vanbt
infect
caus
tempor
defin
express
lung
cytokin
elicit
lower
respiratori
tract
patholog
cotton
rat
absenc
patholog
inflammatori
antivir
respons
induct
ifninduc
gene
rat
inocul
uvvanbt
indic
respons
replicationdepend
mx
protein
possess
gtpase
activ
abil
form
oligom
import
mediat
ifndepend
antivir
activ
induct
time
antivir
respons
cotton
rat
fulli
function
mx
gene
may
underli
shortliv
replic
cycl
vanbt
cotton
rat
observ
mild
inflamm
lung
infect
anim
possibl
limit
cell
could
infect
vanbt
cotton
rat
howev
suggest
healthi
adult
usual
show
milder
rang
respiratori
symptom
upon
infect
similar
describ
cotton
rat
interestingli
infect
report
adult
patient
hematolog
malign
hematopoiet
cell
transplant
recipi
show
mild
upper
respiratori
symptom
respiratori
failur
thu
would
import
measur
vanbt
replic
immunocompromis
cyclophosphamid
treatment
induc
cotton
rat
block
product
cotton
rat
upper
respiratori
tract
cell
vitro
children
higher
risk
sever
respiratori
symptom
due
infect
would
pertin
evalu
replic
younger
cotton
rat
cotton
rat
pup
day
old
tight
correl
signific
differ
infect
profil
three
strain
cotton
rat
observ
strain
differ
capac
induc
na
follow
infect
im
immun
atcc
induc
lowest
titer
vanbt
elicit
highest
homolog
na
respons
fig
fig
tabl
basi
hemagglutin
inhibit
hi
na
titer
previous
shown
fermon
strain
lower
hi
na
titer
recent
detect
strain
may
explain
atcc
lower
antigen
lead
induct
lower
na
titer
hi
na
titer
also
shown
significantli
differ
strain
differ
genet
clade
among
recent
detect
strain
compar
vanbt
atcc
elicit
essenti
neglig
heterolog
na
titer
tabl
recent
studi
use
bayesian
markov
chain
mont
carlo
approach
estim
genet
divers
region
increas
late
may
result
emerg
three
clade
suggest
atcc
prototyp
strain
isol
could
differ
vastli
term
antigen
characterist
even
replic
human
shown
cotton
rat
compar
recent
vanbt
strain
previous
show
infect
cotton
rat
compar
dose
show
high
level
viru
replic
nose
trachea
lung
wherea
show
significantli
lower
infecti
viru
titer
tissu
furthermor
report
im
live
vaccin
cotton
rat
gener
high
titer
na
vaccin
anim
elicit
detect
homolog
na
hrv
found
strong
correl
product
high
titer
serum
na
certain
hrv
abil
hrv
replic
airway
cotton
rat
vast
differ
among
three
strain
infect
profil
na
titer
gener
follow
infect
think
correl
rv
infect
cotton
rat
data
show
vanbt
replic
lymph
node
drain
site
im
inocul
fig
thu
increas
chanc
antigen
process
present
macrophag
dendrit
cell
initi
robust
immun
respons
result
passiv
transfer
immun
sera
show
prophylact
administr
vanbt
hyperimmun
serum
protect
nose
lung
tissu
anim
vanbt
challeng
indic
passiv
antibodi
transfer
could
potenti
effect
prophylact
therapi
infect
outbreak
treatment
individu
highrisk
fig
prophylact
antibodi
therapi
infecti
diseas
becom
import
altern
absenc
vaccin
respigam
tm
synagi
tm
rsv
recent
zmapp
tm
ebola
viru
assess
differ
immun
use
live
uvinactiv
vanbt
challeng
found
im
immun
live
vanbt
live
atcc
result
decreas
viral
load
nose
lung
tissu
fig
though
infect
vanbt
result
induct
na
titer
fig
anim
previous
infect
vanbt
show
signific
protect
reinfect
fig
suggest
infect
fail
provid
degre
immun
induc
infect
respiratori
virus
model
ie
influenza
rsv
infect
induc
complet
protect
reinfect
howev
similar
result
seen
infect
hrv
replic
cotton
rat
protect
reinfect
moder
protect
achiev
live
immun
vanbt
challeng
fig
consist
capac
gener
detect
heterolog
na
vanbt
tabl
result
clearli
demonstr
gener
crossstrain
na
respons
confer
immun
live
belong
differ
clade
could
serv
tool
defin
conserv
antigen
featur
use
candid
induc
broadspectrum
immun
differ
clade
thu
warrant
investig
basi
pulmonari
cytokin
analysi
immun
anim
challeng
conclud
live
im
vanbtimmun
anim
mount
strong
respons
uvvanbt
im
immun
group
show
excess
respons
could
predispos
develop
allerg
respons
similarli
previous
shown
uvinactiv
virus
use
immun
propens
develop
respons
enhanc
respiratori
diseas
first
time
studi
assess
effect
immun
crude
vaccin
prepar
given
im
despit
efficaci
im
immun
vanbt
reduc
viral
titer
vivo
anim
vaccin
im
uvvanbt
vanbt
enhanc
cytokin
respons
lung
histopatholog
rais
possibl
preexist
immun
virus
could
deleteri
effect
associ
acut
flaccid
paralysi
children
definit
rais
safeti
issu
vaccin
develop
data
serv
emphas
live
vaccin
gener
high
titer
na
could
use
defin
mechan
immun
viru
futur
studi
develop
either
liveattenu
vaccin
inactiv
whole
viru
vaccin
viruslik
particlebas
vaccin
recombin
protein
base
vaccin
vari
dosag
inclus
adjuv
formul
safe
vaccin
logic
next
step
reduc
potenti
advers
effect
regard
previous
shown
formalininactiv
rsv
vaccin
shown
induc
vaccin
enhanc
diseas
clinic
trial
could
render
safe
model
inclus
agonist
adjuv
monophosphoryl
lipid
use
clinic
isol
human
patient
without
adapt
infect
cotton
rat
one
biggest
advantag
model
clear
viru
adapt
introduc
consider
number
nucleotid
variat
viral
genom
may
dramat
alter
cours
natur
infect
despit
varieti
geograph
sourc
strain
detect
recent
year
similar
sequenc
long
belong
genet
clade
previou
studi
shown
virus
clade
c
circul
cocircul
differ
time
period
differ
geograph
locat
thu
possibl
antigen
differ
strain
belong
cladesubclad
differ
geograph
distanc
minim
therefor
hypothes
cotton
rat
model
could
import
tool
infect
current
futur
isol
detect
geograph
locat
assess
vaccin
strategi
antivir
molecul
anim
work
present
paper
conduct
strict
accord
recommend
guid
care
use
laboratori
anim
nation
institut
health
anim
protocol
protocol
approv
institut
anim
care
use
committe
iacuc
sigmovir
biosystem
inc
sbi
olaw
assur
sbi
usda
breed
research
licens
respect
accredit
associ
assess
accredit
laboratori
anim
care
aaalac
four
six
week
old
femal
cotton
rat
obtain
inbr
coloni
maintain
sbi
cotton
rat
coloni
seroneg
neutral
assay
seroneg
elisa
adventiti
respiratori
virus
eg
pneumonia
viru
mice
rat
parvoviru
rat
coronaviru
sendai
viru
anim
hous
larg
polycarbon
cage
fed
diet
standard
rodent
chow
water
ad
libitum
cotton
rat
infect
immun
intramuscularli
im
three
differ
strain
isofluran
anesthesia
inocul
viru
prepar
tissu
cultur
infect
dose
tcid
per
rat
serum
sampl
obtain
retroorbit
blood
collect
isofluran
anesthesia
anim
euthan
carbon
dioxid
asphyxi
three
strain
studi
atcc
access
prototyp
fermon
viru
strain
purchas
american
type
cultur
collect
atcc
manassa
va
suppli
dr
tina
v
hartert
access
collect
nashvil
tn
vanderbilt
univers
medic
center
preoutbreak
isol
bei
resourc
niaid
access
collect
kansa
citi
outbreak
usa
fig
viru
stock
produc
hela
cell
atcc
manassa
va
grown
dmem
lonza
fb
seradigm
co
five
day
pi
cell
freezethaw
time
vortex
vigor
releas
cell
associ
virus
centrifug
x
g
determin
tcid
replicationdefici
viru
gener
expos
viru
stock
ultraviolet
light
min
tissu
sampl
left
lung
lobe
entir
nose
homogen
ml
homogen
buffer
emem
spg
fungizon
gentamycin
differ
timepoint
pi
infecti
viru
titer
determin
standard
endpoint
dilut
assay
express
tcid
g
tissu
briefli
overnight
incub
hela
cell
well
plate
wash
serum
free
medium
infect
serial
dilut
freezethaw
tissu
homogen
cell
viabil
assess
crystal
violet
stain
assay
repeat
least
three
time
three
five
replic
per
assay
viru
neutral
perform
incub
serial
dilut
immun
control
cotton
rat
sera
tcid
viruswel
well
plate
day
incub
cell
viabil
assess
assay
repeat
least
three
time
four
replic
per
assay
run
contain
cell
control
plate
back
titrat
plate
viru
rna
isol
lung
lingular
lobe
use
rnaeasi
kit
qiagen
scienc
cdna
prepar
quantitect
revers
transcript
kit
qiagen
scienc
ii
revers
transcriptas
thermo
fisher
scientif
cdna
reaction
prepar
initi
rna
dilut
final
volum
three
cdna
subsequ
use
pcr
reaction
specif
qrtpcr
develop
use
primer
target
tabl
quantifi
viral
replic
cdna
neg
strand
viral
rna
indic
activ
rna
transcript
synthes
prime
forward
primer
flank
start
sequenc
primer
pcr
reaction
perform
use
intern
nest
primer
vanbt
vanbt
entir
pcr
amplicon
use
primer
gel
purifi
dilut
gener
copi
number
standard
curv
use
quantifi
copiesg
tissu
neg
viral
rna
assess
cotton
rat
cytokin
mrna
express
carri
use
primer
previous
describ
lung
dissect
en
bloc
right
lobe
inflat
neutral
buffer
formalin
normal
volum
submers
fix
solut
follow
fixat
lung
embed
paraffin
section
stain
use
hematoxylin
eosin
h
e
four
paramet
pulmonari
inflamm
evalu
peribronchiol
inflammatori
cell
infiltr
around
bronchiol
perivascul
inflammatori
cell
infiltr
around
small
blood
vessel
interstiti
pneumonia
inflammatori
cell
infiltr
thicken
alveolar
wall
alveol
cell
within
alveolar
space
slide
score
blindli
scale
absent
minim
mild
moder
mark
viral
titer
na
titer
express
cytokin
gene
total
vrna
vrna
calcul
geometr
mean
standard
error
se
anim
group
given
time
pi
student
ttest
use
determin
statist
signific
differ
two
group
use
unpair
twotail
test
signific
set
p
pulmonari
patholog
score
express
arithmet
mean
se
anim
group
